OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the application and is allowed for treatment of un...
Saved in:
Main Author: | T.V. Kulichenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2007-12-01
|
Series: | Педиатрическая фармакология |
Online Access: | https://www.pedpharma.ru/jour/article/view/689 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OMALIZUMAB-BASED TREATMENT OF TEENAGERS, SUFFERING FROM SEVERE ATOPIC BRONCHIAL ASTHMA
by: T.V. Kulichenko, et al.
Published: (2008-11-01) -
PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA
by: A.S. Kolbin, et al.
Published: (2008-07-01) -
OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01) -
OMALIZUMAB: EXPANDED OPPORTUNITIES FOR THE ATOPIC DISEASES TREATMENT
by: T.V. Kulichenko
Published: (2009-06-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01)